2Hundahl SA, Phillips JL, Menck HR. The National Cancer Data Base Report on poor survival of U. S. gastric carcinoma patients treated with gastrectomy.. Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the "different disease" hypothesis. Cancer, 2000,88:921-932.
5Ichikura T,Tomimatsu S, Uefuii K, et al. Evaluation of the New American Joint Committee on Cancer/International Union against cancer classification of lymph node metastasis from gastric carcinoma in comparison with the Japanese classification. Cancer,1999,86: 553-558.
8Hartgrink HH,van de Velde CJ,Putter H,et al. Extended lymphnode dissection for gastric cancer: Who may benefit? Final resuits of the randomized Dutch gastric cancer group trial. J Clin Oncol, 2004,22 : 2069-2077.
9Hartgrink HH,van de Velde CJ. Status of extended lymph node dissection: Locoregional control is the only way to survive gastric cancer. J Surg Oncol,2005,90:153-165.
10Sano T, Sasako M, Yamamoto S, et al. Gastric cancer surgery:Morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy-Japan Clinical Oncology Group study 9501. J Clin Oncol, 2004,22 : 2767-2773.
6Maehara Y, Moriguchi S, Yoshida M, et al. Splenectomy does not correlate with length of survival in patients undergoing curative total gastrectomy for gastric carcinoma. Univariate and multivariate analyses. Cancer, 1991, 67:3006-3009.
7Okajima K, Isozaki H. Spleneetomy for treatment of gastric cancer:Japanese experience. World J Surg, 1995, 19:537-540.
9Schmid A, Thybusch A, Kremer B, et al. Differential effects of radical D2-1ymphadenectomy and splenectomy in surgically treated gastric cancer patients. Hepatogastroenterology, 2000, 47:579-585.
10Yoshino K, Yamada Y, Asanuma F, et al. Splenectomy in cancer gastrectomy: recommendation of spleen-preserving for early stages.Int Surg, 1997, 82 : 150-154.
